⌘K

Login Start Free

Home/Filings/4/0001209191-21-014641

4//SEC Filing

Smith David V 4

Accession 0001209191-21-014641

CIK 0001175505other

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 2:31 PM ET

Size

4.7 KB

Accession

0001209191-21-014641

Insider Transaction Report

Form 4

Period: 2021-02-24

FIVE PRIME THERAPEUTICS, INC.FPRX

Executive Vice President & CFO

Transactions

Tax Payment
Common Stock
2021-02-24$25.71/sh−5,110$131,378→ 72,947 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

FIVE PRIME THERAPEUTICS, INC.

CIK 0001175505

Entity typeother

Related Parties

1

filerCIK 0001229447

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 2:31 PM ET
Size: 4.7 KB

View on SEC.gov